Home » Rosetta Launches Collaborations to Advance Fluids-Based Diagnostic Tests
Rosetta Launches Collaborations to Advance Fluids-Based Diagnostic Tests
Rosetta Genomics, Ltd. announced that it has signed two new agreements for the development and validation of microRNA-based diagnostics for various indications related to its Gen 3 products.
iStockAnalyst
iStockAnalyst
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May